Tagitol V

NDC product · U.S. Food and Drug Administration (openFDA) · United States

  • Product NDC 32909-814
  • Package NDC 32909-814-55
  • Application number NDA208143
  • SPL ID e58e233f-e14d-4e54-93cc-05c6ad63882b
  • SPL set ID 30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0
  • UNII 25BB7EKE2E

What the source publishes

Labeler
E-Z-EM Canada Inc
Active ingredients
Barium Sulfate
Form
SUSPENSION
Routes
ORAL
Administrative status
present-in-source-snapshot
Marketing status
NDA
Product type
HUMAN PRESCRIPTION DRUG
Prescription
Prescription or restricted

Names this record is found by

Complete source data
us:fda:ndc:32909-814_e58e233f-e14d-4e54-93cc-05c6ad63882b
{
  "name": "Tagitol V",
  "splId": "e58e233f-e14d-4e54-93cc-05c6ad63882b",
  "labels": [
    {
      "setId": "30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0",
      "labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0",
      "labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0"
    }
  ],
  "routes": [
    "ORAL"
  ],
  "labeler": "E-Z-EM Canada Inc",
  "finished": true,
  "packaging": [
    {
      "sample": false,
      "description": "24 BOX in 1 CASE (32909-814-55)  / 3 BOTTLE, GLASS in 1 BOX / 20 mL in 1 BOTTLE, GLASS",
      "package_ndc": "32909-814-55",
      "identifierStatus": "well-formed",
      "marketing_start_date": "20221001"
    }
  ],
  "productId": "32909-814_e58e233f-e14d-4e54-93cc-05c6ad63882b",
  "useDomain": "unknown",
  "dosageForm": "SUSPENSION",
  "productNdc": "32909-814",
  "deaSchedule": null,
  "genericName": "Barium Sulfate",
  "productType": "HUMAN PRESCRIPTION DRUG",
  "listingStatus": "present-in-source-snapshot",
  "targetSpecies": [],
  "approvalStatus": "not-established-by-ndc-listing",
  "labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
  "marketingEndDate": null,
  "activeIngredients": [
    {
      "name": "BARIUM SULFATE",
      "strength": "400 mg/mL"
    }
  ],
  "applicationNumber": "NDA208143",
  "marketingCategory": "NDA",
  "stateRestrictions": {
    "status": "not-collected",
    "observations": []
  },
  "useDomainEvidence": {
    "basis": "unreviewed",
    "field": null,
    "value": null,
    "version": 1,
    "sourceId": "us.fda.ndc"
  },
  "marketingStartDate": "20170804",
  "targetSpeciesStatus": "not-reported",
  "prescriptionCategory": "prescription-or-restricted",
  "harmonizedIdentifiers": {
    "nui": [
      "N0000180185",
      "N0000010258"
    ],
    "unii": [
      "25BB7EKE2E"
    ],
    "spl_set_id": [
      "30c68756-c7db-bf50-9cd5-ef4b0c7ab1d0"
    ],
    "pharm_class_epc": [
      "Radiographic Contrast Agent [EPC]"
    ],
    "pharm_class_moa": [
      "X-Ray Contrast Activity [MoA]"
    ],
    "manufacturer_name": [
      "E-Z-EM Canada Inc"
    ],
    "is_original_packager": [
      true
    ]
  },
  "listingExpirationDate": "20271231"
}

Read this record from your own software

The same record, with every field and its provenance, is one request away. An API key is free and works immediately.

GET /v1/drugs/record
curl -G "https://api.medifontis.com/v1/drugs/record" \
  -H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
  --data-urlencode "country=us" \
  --data-urlencode "sourceId=us.fda.ndc" \
  --data-urlencode "id=us:fda:ndc:32909-814_e58e233f-e14d-4e54-93cc-05c6ad63882b"